Related Experiment Video
Updated: Feb 4, 2026

Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
Potential Regulatory Roles of MicroRNAs and Long Noncoding RNAs in Anticancer Therapies
Mengyan Xie1, Ling Ma1, Tongpeng Xu1
1Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Abstract:
MicroRNAs and long noncoding RNAs have long been investigated due to their roles as diagnostic and prognostic biomarkers of cancers and regulators of tumorigenesis, and the potential regulatory roles of these molecules in anticancer therapies are attracting increasing interest as more in-depth studies are performed. The major clinical therapies for cancer include chemotherapy, immunotherapy, and targeted molecular therapy. MicroRNAs and long noncoding RNAs function through various mechanisms in these approaches, and the mechanisms involve direct targeting of immune checkpoints, cooperation with exosomes in the tumor microenvironment, and alteration of drug resistance through regulation of different signaling pathways. Herein we review the regulatory functions and significance of microRNAs and long noncoding RNAs in three anticancer therapies, especially in targeted molecular therapy, and their mechanisms.
Insights
MicroRNAs and long noncoding RNAs are key regulators in cancer. These molecules show potential in anticancer therapies by targeting immune checkpoints and altering drug resistance.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are investigated as cancer biomarkers and regulators of tumorigenesis.
- Their roles in anticancer therapies are gaining attention.
- Current cancer therapies include chemotherapy, immunotherapy, and targeted molecular therapy.
Purpose of the Study:
- To review the regulatory functions and significance of miRNAs and lncRNAs in anticancer therapies.
- To focus on their mechanisms, particularly in targeted molecular therapy.
Main Methods:
- Literature review of studies on miRNAs and lncRNAs in cancer therapy.
- Analysis of mechanisms including immune checkpoint targeting, exosome cooperation, and drug resistance regulation.
Main Results:
- miRNAs and lncRNAs play diverse roles in chemotherapy, immunotherapy, and targeted therapy.
- Mechanisms involve direct immune checkpoint modulation, exosome-mediated communication in the tumor microenvironment, and influencing drug resistance via signaling pathways.
Conclusions:
- miRNAs and lncRNAs are significant regulatory molecules in anticancer strategies.
- Their intricate mechanisms offer potential for developing novel therapeutic approaches, especially in targeted therapy.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
piRNA - Piwi-interacting RNAs
Cis-regulatory Sequences

